Cash Flow from Operating Activities: A company's cash flows from operations.
Biogen Inc. (BIIB) had Cash Flow from Operating Activities of $2.20B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$9.89B |
|
$1.29B |
|
$2.40B |
|
$7.49B |
|
$8.03B |
|
$1.86B |
|
$-305.60M |
|
$1.56B |
|
$1.56B |
|
$1.29B |
|
$1.29B |
|
$1.29B |
|
$1.29B |
|
$1.86B |
|
$2.94B |
|
146.50M |
|
147.10M |
|
$8.83 |
|
$8.79 |
|
| Balance Sheet Financials | |
$8.97B |
|
$3.06B |
|
$20.47B |
|
$29.44B |
|
$3.35B |
|
$6.29B |
|
$7.83B |
|
$11.18B |
|
$18.26B |
|
$2.59B |
|
$18.26B |
|
146.70M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$2.20B |
$-1.37B |
|
$-301.90M |
|
$2.38B |
|
$3.01B |
|
$633.50M |
|
$290.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.68 |
|
-- |
|
-- |
|
0.26 |
|
0.34 |
|
75.69% |
|
18.83% |
|
18.83% |
|
29.68% |
|
15.74% |
|
13.07% |
|
$2.05B |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
1.11 |
|
7.37 |
|
49.54 |
|
7.08% |
|
49.97% |
|
4.39% |
|
5.27% |
|
$124.45 |
|
$13.94 |
|
$14.99 |
|